ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

Also MSKCC picks David Kissane to succeed Jimmie Holland as chairman of psychiatry and behavioral sciences.

October 24, 2003

Most Older Men With Early Prostate Cancer Can Avoid Treatment, Analysis Finds

February 29, 2008

NIH Offers Grant Funds for Support of Minority, Disabled Researchers

February 16, 1996

Groups Advise NCI On “Investment Opportunities”

June 28, 1996

DCPC Advisors Okay New Grant Programs To Improve Participation Of Women, Minorities In Clinical Trials

May 26, 1995

House Appropriators Approve NIH Increase; Clinton Threatens Veto Over Education Cuts

July 17, 1998